Federal Register #2026-20104

CMS Seeks Comments on Medicare Part D Prescription Drug Event Data Collection

The Centers for Medicare & Medicaid Services (CMS), within the Department of Health and Human Services (HHS), is seeking public comments on a proposed revision to its Medicare Part D Prescription Drug Event data collection. - Government buyer: CMS, HHS. - Notice purpose: Comments are sought on “Collection of Prescription Drug Event Data from Contracted Part D Providers for Payment” (CMS-10174; OMB control number 0938-0982). This is an information-collection notice, not a procurement solicitation. - Data use: Claims-level Prescription Drug Event data supports Medicare Part D payment calculations, claim validation, quality monitoring, program integrity, and oversight. - Affected parties: Pharmacy benefit managers, third-party administrators, pharmacies, prescription drug plans, Medicare Advantage prescription drug plans, fallback plans, and other plans offering Medicare Part D outpatient drug coverage. - Estimated collection burden: 994 respondents, 1,627,798,686 annual responses, and 11,208 annual hours. - Products and services: No products or services are being requested for purchase; no OEMs, vendors, or product line items are identified.

Description

The Centers for Medicare & Medicaid Services (CMS) invites public comments on a proposed revision to its information collection, “Collection of Prescription Drug Event Data from Contracted Part D Providers for Payment.” The collected claims-level data supports accurate Medicare Part D payment calculations, validation, quality monitoring, program integrity, and oversight. The notice identifies pharmacies, pharmacy benefit managers, third-party administrators, and plans offering Medicare Part D coverage among the users or affected parties. Comments must be received by the OMB desk officer by November 2, 2026.

View original listing